MUMBAI, India and NEW YORK , May 23, 2024 /PRNewswire/ -- Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA , BSE: 524715) (together with its subsidiaries and/or associates referred as "Sun Pharma") and Taro Pharmaceutical Industries Ltd.
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 20, 2024-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro” or the “Company”) today provided unaudited financial results for the quarter and year ended March 31, 2024 . Quarter ended March 31, 2024 Highlights ─ compared to March 31, 2023 Net sales of
HAWTHORNE, N.Y. --(BUSINESS WIRE)--May 15, 2024-- Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2024 , after the close of market on Monday, May 20, 2024 . The release will be accessible on Taro’s website at
Alerts are e-mailed to you whenever certain new company information is posted to this site.
